STAA - スタ―サ―ジカル (STAAR Surgical Company)

STAAのニュース

   Broadwood Partners, L.P. Sells 48,687 Shares of STAAR Surgical (NASDAQ:STAA) Stock  2021/02/06 09:36:41 Watchlist News
STAAR Surgical (NASDAQ:STAA) major shareholder Broadwood Partners, L.P. sold 48,687 shares of STAAR Surgical stock in a transaction on Thursday, February 4th. The shares were sold at an average price of $111.15, for a total value of $5,411,560.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available […]
   Elizabeth Yeu, M.D. and K. Peony Yu, M.D. Appointed to STAAR Surgical Board of Directors  2021/01/26 15:45:00 Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the appointments of Elizabeth Yeu, M.D., Partner, Virginia Eye Consultants, and K. Peony Yu, M.D., retired Chief Medical Officer, FibroGen Inc., to its Board of Directors, effective January 21, 2021. “The addition of Dr. Elizabeth Yeu and Dr. K. Peony Yu to our Board of Directors illustrates
   Canaccord Genuity Stick to Their Buy Rating for Staar Surgical Company By Investing.com  2021/01/11 11:05:22 Investing.com
Canaccord Genuity Stick to Their Buy Rating for Staar Surgical Company
   Bragar Eagel & Squire is Investigating Certain Officers and Directors of Peabody Energy Corporation, EQT Corporation, Exela Technologies, and STAAR Surgical and Encourages Investors to Contact the Firm - Stocks News Feed  2021/01/06 01:00:00 Stocks News Feed
NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Peabody Energy Corporation (NYSE: BTU), EQT Corporation (NYSE: EQT), Exela Technologies, Inc. (NASDAQ: XELA), and STAAR Surgical Company (NASDAQ: STAA) on behalf of long-term stockholders. More information about… Read More »Bragar Eagel & Squire is Investigating Certain Officers and Directors of Peabody Energy Corporation, EQT Corporation, Exela Technologies, and STAAR Surgical and Encourages Investors to Contact the Firm
   STAAR Surgical Reports Third Quarter 2020 Results  2020/11/04 21:01:00 Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended October 2, 2020. Third Quarter 2020 Overview Record Quarterly Net Sales of $47.1 Million Up 21% from the Prior Year Quarter Record Quarterly ICL Sales of $41.5 Million Up 23% from the Prior Year Quarter Record Quarterly ICL Units, Up 25% from the P
   Canaccord Genuity Stick to Their Buy Rating for Staar Surgical Company By Investing.com  2021/01/11 11:05:22 Investing.com
Canaccord Genuity Stick to Their Buy Rating for Staar Surgical Company
   Bragar Eagel & Squire is Investigating Certain Officers and Directors of Peabody Energy Corporation, EQT Corporation, Exela Technologies, and STAAR Surgical and Encourages Investors to Contact the Firm - Stocks News Feed  2021/01/06 01:00:00 Stocks News Feed
NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Peabody Energy Corporation (NYSE: BTU), EQT Corporation (NYSE: EQT), Exela Technologies, Inc. (NASDAQ: XELA), and STAAR Surgical Company (NASDAQ: STAA) on behalf of long-term stockholders. More information about… Read More »Bragar Eagel & Squire is Investigating Certain Officers and Directors of Peabody Energy Corporation, EQT Corporation, Exela Technologies, and STAAR Surgical and Encourages Investors to Contact the Firm
   STAAR Surgical Reports Third Quarter 2020 Results  2020/11/04 21:01:00 Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended October 2, 2020. Third Quarter 2020 Overview Record Quarterly Net Sales of $47.1 Million Up 21% from the Prior Year Quarter Record Quarterly ICL Sales of $41.5 Million Up 23% from the Prior Year Quarter Record Quarterly ICL Units, Up 25% from the P
   STAAR Surgical worth buying post Earnings results? Stock market Insights & financial analysis  2020/11/04 14:40:00 Stock Market Daily
STAAR Surgical announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   STAAR Surgical (NASDAQ:STAA) Rating Increased to Strong-Buy at BidaskClub  2020/10/25 05:02:49 The Lincolnian
STAAR Surgical (NASDAQ:STAA) was upgraded by investment analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a report issued on Friday, BidAskClub reports. Several other research analysts have also recently weighed in on the company. BTIG Research reaffirmed a “hold” rating on shares of STAAR Surgical in a research report on Friday, […]
   STAAR Surgical Reports Third Quarter 2020 Results  2020/11/04 21:01:00 Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended October 2, 2020. Third Quarter 2020 Overview Record Quarterly Net Sales of $47.1 Million Up 21% from the Prior Year Quarter Record Quarterly ICL Sales of $41.5 Million Up 23% from the Prior Year Quarter Record Quarterly ICL Units, Up 25% from the P
   STAAR Surgical worth buying post Earnings results? Stock market Insights & financial analysis  2020/11/04 14:40:00 Stock Market Daily
STAAR Surgical announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   STAAR Surgical (NASDAQ:STAA) Rating Increased to Strong-Buy at BidaskClub  2020/10/25 05:02:49 The Lincolnian
STAAR Surgical (NASDAQ:STAA) was upgraded by investment analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a report issued on Friday, BidAskClub reports. Several other research analysts have also recently weighed in on the company. BTIG Research reaffirmed a “hold” rating on shares of STAAR Surgical in a research report on Friday, […]
   STAAR Surgical to Report Third Quarter Results on November 4, 2020  2020/10/21 11:00:00 Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended October 2, 2020 on Wednesday, November 4, 2020 after the market close. STAAR will host a conference call and webcast on Wednesday, November 4 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operat
   STAAR Surgical (NASDAQ:STAA) Rating Increased to Buy at ValuEngine  2020/10/21 05:34:43 Zolmax News
STAAR Surgical (NASDAQ:STAA) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investors on Monday, ValuEngine reports. A number of other brokerages have also recently issued reports on STAA. Sidoti upgraded STAAR Surgical from a “neutral” rating to a “buy” rating and set […]

calendar